Price · as of 2026-09-03
$25.87
Market cap 1.54B
Price history
| Week | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jan 27, 2025 – Jan 31, 2025 | $16.12 | $17.00 | $15.25 | $15.95 | |
| Feb 3, 2025 – Feb 7, 2025 | $15.90 | $16.09 | $11.34 | $13.38 | 0 |
| Feb 10, 2025 – Feb 14, 2025 | $13.12 | $14.18 | $10.92 | $12.00 | 0 |
| Feb 17, 2025 – Feb 21, 2025 | $11.75 | $13.42 | $10.80 | $12.09 | 0 |
| Feb 24, 2025 – Feb 28, 2025 | $12.09 | $13.24 | $10.08 | $12.23 | 0 |
| Mar 3, 2025 – Mar 7, 2025 | $12.17 | $13.04 | $10.61 | $12.00 | 0 |
| Mar 10, 2025 – Mar 14, 2025 | $11.93 | $12.88 | $10.54 | $10.99 | 0 |
| Mar 17, 2025 – Mar 21, 2025 | $10.85 | $13.00 | $9.88 | $11.14 | 0 |
| Mar 24, 2025 – Mar 28, 2025 | $11.03 | $12.37 | $10.41 | $11.42 | 0 |
| Mar 31, 2025 – Apr 4, 2025 | $10.91 | $11.94 | $8.33 | $9.07 | 0 |
| Apr 7, 2025 – Apr 11, 2025 | $9.09 | $9.43 | $6.71 | $7.83 | 0 |
| Apr 14, 2025 – Apr 17, 2025 | $8.10 | $9.13 | $7.52 | $8.41 | 0 |
| Apr 21, 2025 – Apr 25, 2025 | $8.38 | $10.73 | $7.16 | $8.21 | 0 |
| Apr 28, 2025 – May 2, 2025 | $8.25 | $11.98 | $7.79 | $10.85 | 0 |
| May 5, 2025 – May 9, 2025 | $10.50 | $10.74 | $8.77 | $9.62 | 0 |
| May 12, 2025 – May 16, 2025 | $10.04 | $10.39 | $8.24 | $9.25 | 0 |
| May 19, 2025 – May 23, 2025 | $9.24 | $10.63 | $9.15 | $10.28 | 0 |
| May 26, 2025 – May 30, 2025 | $10.58 | $12.25 | $9.73 | $10.01 | 0 |
| Jun 2, 2025 – Jun 6, 2025 | $10.08 | $14.40 | $10.08 | $12.93 | 0 |
| Jun 9, 2025 – Jun 13, 2025 | $13.23 | $13.86 | $12.27 | $13.40 | 0 |
| Jun 16, 2025 – Jun 20, 2025 | $13.58 | $13.84 | $10.49 | $11.18 | 0 |
| Jun 23, 2025 – Jun 27, 2025 | $11.13 | $12.93 | $9.83 | $12.13 | 0 |
| Jun 30, 2025 – Jul 3, 2025 | $12.23 | $13.47 | $10.98 | $11.50 | 0 |
| Jul 7, 2025 – Jul 11, 2025 | $11.53 | $15.84 | $11.34 | $15.05 | 0 |
| Jul 14, 2025 – Jul 18, 2025 | $14.83 | $18.50 | $14.35 | $17.78 | 0 |
| Jul 21, 2025 – Jul 25, 2025 | $18.26 | $19.19 | $15.17 | $16.82 | 0 |
| Jul 28, 2025 – Aug 1, 2025 | $17.07 | $17.38 | $13.82 | $14.90 | 0 |
| Aug 4, 2025 – Aug 8, 2025 | $14.93 | $15.85 | $12.90 | $13.14 | 0 |
| Aug 11, 2025 – Aug 15, 2025 | $13.07 | $14.56 | $12.86 | $13.50 | 0 |
| Aug 18, 2025 – Aug 22, 2025 | $13.49 | $14.02 | $12.81 | $13.49 | 0 |
| Aug 25, 2025 – Aug 29, 2025 | $13.47 | $14.85 | $12.91 | $14.49 | 0 |
| Sep 1, 2025 – Sep 5, 2025 | $14.64 | $16.40 | $14.16 | $15.88 | 0 |
| Sep 8, 2025 – Sep 12, 2025 | $16.05 | $25.50 | $14.75 | $23.30 | 0 |
| Sep 15, 2025 – Sep 19, 2025 | $23.33 | $25.18 | $22.04 | $22.94 | 0 |
| Sep 22, 2025 – Sep 26, 2025 | $22.86 | $28.37 | $22.45 | $27.00 | 0 |
| Sep 29, 2025 – Oct 3, 2025 | $27.05 | $27.83 | $24.42 | $27.11 | 0 |
| Oct 6, 2025 – Oct 10, 2025 | $27.79 | $29.66 | $26.43 | $27.43 | 0 |
| Oct 13, 2025 – Oct 17, 2025 | $27.43 | $29.76 | $27.41 | $27.81 | 0 |
| Oct 20, 2025 – Oct 24, 2025 | $27.79 | $31.93 | $27.79 | $30.39 | 0 |
| Oct 27, 2025 – Oct 31, 2025 | $30.87 | $34.29 | $30.32 | $32.91 | 0 |
| Nov 3, 2025 – Nov 7, 2025 | $32.36 | $33.74 | $26.96 | $28.60 | 0 |
| Nov 10, 2025 – Nov 14, 2025 | $28.17 | $33.76 | $28.17 | $32.53 | 0 |
| Nov 17, 2025 – Nov 21, 2025 | $32.52 | $37.23 | $31.47 | $36.26 | 0 |
| Nov 24, 2025 – Nov 28, 2025 | $36.99 | $38.85 | $35.93 | $37.75 | 0 |
| Dec 1, 2025 – Dec 5, 2025 | $37.66 | $43.29 | $36.84 | $41.71 | 0 |
| Dec 8, 2025 – Dec 12, 2025 | $42.14 | $42.50 | $38.10 | $38.86 | 0 |
| Dec 15, 2025 – Dec 19, 2025 | $39.44 | $42.59 | $38.28 | $41.71 | 0 |
| Dec 22, 2025 – Dec 26, 2025 | $41.71 | $43.17 | $41.12 | $42.10 | 0 |
| Dec 29, 2025 – Jan 2, 2026 | $41.51 | $41.83 | $38.13 | $39.77 | 0 |
| Jan 5, 2026 – Jan 9, 2026 | $39.77 | $40.99 | $37.37 | $40.32 | 0 |
| Jan 12, 2026 – Jan 16, 2026 | $40.17 | $41.79 | $38.00 | $40.77 | 0 |
| Jan 19, 2026 – Jan 23, 2026 | $40.13 | $47.36 | $38.62 | $44.27 | 0 |
| Jan 26, 2026 – Jan 30, 2026 | $44.20 | $46.99 | $42.22 | $43.58 | 0 |
| Feb 2, 2026 – Feb 6, 2026 | $43.56 | $49.25 | $42.17 | $45.03 | 0 |
| Feb 9, 2026 – Feb 13, 2026 | $45.09 | $48.76 | $43.89 | $46.01 | 0 |
| Feb 16, 2026 – Feb 20, 2026 | $46.01 | $48.03 | $42.56 | $44.22 | 0 |
| Feb 23, 2026 – Feb 27, 2026 | $44.83 | $47.49 | $44.20 | $45.59 | 0 |
| Mar 2, 2026 – Mar 6, 2026 | $44.50 | $46.65 | $43.00 | $44.83 | 0 |
| Mar 9, 2026 – Mar 13, 2026 | $44.00 | $52.86 | $42.88 | $50.21 | 0 |
| Mar 16, 2026 – Mar 20, 2026 | $50.96 | $53.65 | $46.67 | $48.03 | 0 |
| Mar 23, 2026 – Mar 27, 2026 | $48.87 | $49.25 | $29.16 | $30.38 | 0 |
| Mar 30, 2026 – Apr 2, 2026 | $30.37 | $31.23 | $28.00 | $28.71 | 0 |
| Apr 6, 2026 – Apr 10, 2026 | $28.74 | $29.61 | $26.16 | $26.69 | 0 |
| Apr 13, 2026 – Apr 17, 2026 | $27.10 | $29.06 | $26.45 | $28.09 | 0 |
| Apr 20, 2026 – Apr 24, 2026 | $28.05 | $29.09 | $25.10 | $25.81 | 0 |
| Apr 27, 2026 – May 1, 2026 | $25.72 | $27.58 | $25.08 | $27.17 | 0 |
| May 4, 2026 – May 8, 2026 | $26.81 | $28.18 | $24.80 | $26.03 | 0 |
| May 11, 2026 – May 15, 2026 | $26.22 | $27.13 | $25.02 | $25.56 | 0 |
| May 18, 2026 – May 22, 2026 | $25.54 | $26.09 | $23.76 | $25.78 | 0 |
| May 25, 2026 – May 29, 2026 | $25.78 | $26.79 | $25.00 | $26.46 | 0 |
| Jun 1, 2026 – Jun 5, 2026 | $26.32 | $26.54 | $23.62 | $24.27 | 0 |
| Jun 8, 2026 – Jun 12, 2026 | $24.76 | $25.08 | $22.71 | $24.05 | 0 |
| Jun 15, 2026 – Jun 18, 2026 | $24.33 | $25.84 | $23.50 | $25.68 | 0 |
| Jun 22, 2026 – Jun 26, 2026 | $25.69 | $29.95 | $25.24 | $28.43 | 0 |
| Jun 29, 2026 – Jul 2, 2026 | $28.02 | $31.32 | $27.80 | $31.26 | 0 |
| Jul 6, 2026 – Jul 10, 2026 | $31.25 | $33.50 | $28.99 | $30.57 | 0 |
| Jul 13, 2026 – Jul 17, 2026 | $30.04 | $30.56 | $26.37 | $28.12 | 0 |
| Jul 20, 2026 – Jul 24, 2026 | $28.11 | $29.54 | $27.39 | $27.68 | 0 |
| Jul 27, 2026 – Jul 31, 2026 | $27.69 | $29.35 | $25.85 | $26.92 | 0 |
| Aug 3, 2026 – Aug 7, 2026 | $26.74 | $29.00 | $25.85 | $28.65 | 0 |
| Aug 10, 2026 – Aug 14, 2026 | $28.57 | $28.92 | $26.42 | $27.18 | 0 |
| Aug 17, 2026 – Aug 21, 2026 | $27.04 | $30.19 | $27.00 | $29.43 | 0 |
| Aug 24, 2026 – Aug 28, 2026 | $29.27 | $30.80 | $27.31 | $27.44 | 0 |
| Aug 31, 2026 – Sep 3, 2026 | $27.17 | $27.44 | $25.70 | $25.87 | 0 |
Valuation
| Metric | Value | Upside |
|---|---|---|
| IC Value | $7.24 | -72% |
| P/E | -16.46 | |
| P/B | 6.08 | |
| P/S | — | |
| EV/EBITDA | -14.29 | |
| PEG | — | |
| P/TBV | 6.08 |
Valuation history
Annual price overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | IC | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | |||||
| 2022 | |||||
| 2023 | |||||
| 2024 | $12.00 | ||||
| 2025 | $50.21 |
Historic valuation ratios
Pick a category, then toggle metrics to compare.
Line items
Line items
Line items
About Maze Therapeutics, Inc.
Maze Therapeutics, Inc., a clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of kidney and metabolic diseases in the United States. Its lead programs include MZE829, an oral small molecule inhibitor of apolipoprotein L1, or APOL1, which is in phase II clinical trial for the treatment of patients with APOL1 kidney disease; and MZE782, an oral small molecule inhibitor that is in phase II ready clinical trial for the treatment of phenylketonuria and chronic kidney disease. The company also develops MZE001, an investigational oral small molecule inhibitor of muscle-specific glycogen synthase clinical program for the treatment of Pompe disease. It has a license agreement with Trace Neuroscience, Inc. to discovery research program targets UNC13A; the Shionogi & Co., Ltd to research, develop, manufacture, and commercialize MZE001; and Neurocrine Biosciences, Inc. to discover research program that targets ATXN2. The company was formerly known as Modulus Therapeutics, Inc. and changed its name to Maze Therapeutics, Inc. in September 2018. The company was incorporated in 2017 and is based in South San Francisco, California.
- CEO
- Jason Coloma
- Employees
- 141
- Beta
- 2.14
Scroll horizontally for additional metrics. Ticker column stays fixed.
| Basic Info | IC Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | Value | Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| MAZE | Maze Therapeutics, Inc. | $28.65 | 1.54B | $7.24 | -75% | -16.46 | 6.08 | — | -14.29 | — | 6.08 | 0.00% | 0.00% | 0.00% | -47.52% | -453.11% | -41.12% | 0.07 | — | 15.50 | 15.16 | 1.29 | -4020.31% | -100.00% | -250.70% | -5.22% | -4.96 | -357.46% | 0.00% | 0.00% | 0.00% | -12.87 | -16.31 | — | 28.78 |
| ARDX | Ardelyx, Inc. | $4.91 | 1.21B | $15.11 | +208% | -22.62 | 8.34 | 3.42 | -45.94 | -42.72 | 8.34 | 89.54% | -10.06% | -15.12% | -36.21% | -43.02% | -13.14% | 1.27 | -1.44 | 4.31 | 3.80 | -4.92 | 52.94% | 22.09% | -4.03% | -3.16% | -0.48 | -46.17% | 0.00% | 0.00% | 0.00% | -32.70 | -30.47 | 3.29 | 1.10 |
| BCRX | BioCryst Pharmaceuticals,… | $9.07 | 2.31B | $71.19 | +685% | 6.54 | -14.48 | 1.97 | 5.43 | — | -14.48 | 97.82% | 38.98% | 30.16% | -88.68% | 752.79% | 52.53% | -3.68 | 4.32 | 2.06 | 1.95 | 1.00 | -381.40% | 94.10% | -716.08% | 18.98% | 1.68 | 732.48% | 0.00% | 0.00% | 22.45% | 5.54 | 5.77 | 2.16 | 1.91 |
| IMNM | Immunome, Inc. | $25.52 | 2.44B | $14.77 | -42% | -8.37 | 2.80 | 256.23 | -5.39 | — | 2.80 | 57.43% | -3084.76% | -3059.99% | -52.09% | 919.14% | -46.00% | 0.01 | — | 14.69 | 14.53 | 3.10 | -51.40% | -23.23% | 22.09% | -11.28% | -4.24 | 861.15% | 0.00% | 0.00% | 28.74% | -5.27 | -5.63 | 162.63 | 20.41 |
| NTLA | Intellia Therapeutics, In… | $10.97 | 1.23B | $9.46 | -14% | -2.66 | 2.06 | 20.44 | -2.59 | — | 2.06 | 76.47% | -651.67% | -609.85% | -67.26% | -110.87% | -51.06% | 0.14 | — | 5.08 | 4.42 | 0.16 | -27.43% | 16.92% | 0.00% | -25.65% | -3.36 | -89.17% | 0.00% | 0.00% | 6.01% | -2.33 | -2.89 | 15.17 | -0.49 |
| PHVS | Pharvaris N.V. | $33.42 | 2.34B | — | — | -7.49 | 4.79 | — | -5.83 | -37.90 | 4.79 | 0.00% | 0.00% | 0.00% | -64.45% | 1070.30% | -58.60% | 0.00 | — | 10.11 | 10.01 | 1.68 | 19.76% | — | 13.73% | -10.55% | -4.63 | 864.94% | 0.00% | 0.00% | 0.85% | -5.95 | -7.36 | — | 22.38 |
| SION | Sionna Therapeutics, Inc. | $47.34 | 2.14B | — | — | -19.81 | 4.86 | — | -16.94 | -57.79 | 4.86 | 0.00% | 0.00% | 0.00% | -105.18% | 80.21% | -29.42% | 0.03 | — | 20.61 | 20.14 | 0.67 | 34.29% | — | 26.24% | -4.47% | -5.66 | 60.10% | 0.00% | 0.00% | 1.46% | -14.21 | -18.96 | — | 45.64 |
| SYRE | Spyre Therapeutics, Inc. | $104.35 | 9.06B | — | — | -16.46 | 3.57 | — | -8.58 | — | 3.57 | 0.00% | 0.00% | 0.00% | -25.17% | 331.08% | -22.39% | 0.00 | — | 13.25 | 12.89 | 0.41 | -37.74% | — | 7.52% | -6.62% | -2.88 | 267.42% | 0.00% | 0.00% | 0.00% | -8.58 | -10.63 | — | 22.70 |
| TRVI | Trevi Therapeutics, Inc. | $18.65 | 2.65B | — | — | -37.36 | 8.72 | — | -33.04 | — | 8.72 | 0.00% | 0.00% | 0.00% | -30.23% | 878.83% | -28.10% | 0.00 | — | 19.66 | 19.41 | 0.43 | -38.30% | — | 9.95% | -2.64% | -4.32 | 751.20% | 0.00% | 0.00% | 0.00% | -28.59 | -33.49 | — | 91.92 |
| WVE | Wave Life Sciences Ltd. | $5.93 | 1.17B | $15.97 | +169% | -10.74 | 4.17 | 51.39 | -8.24 | -14.75 | 4.17 | 79.28% | -504.09% | -478.33% | -55.56% | 343.98% | -41.26% | 0.03 | — | 6.47 | 6.35 | 2.99 | 72.86% | -60.55% | 23.85% | -8.57% | -1.97 | 300.58% | 0.00% | 0.00% | 14.01% | -7.48 | -8.56 | 37.72 | 8.76 |
| ZYME | Zymeworks Inc. | $23.50 | 1.73B | $116.79 | +397% | -21.25 | 6.42 | 16.27 | -22.04 | — | -0.13 | 100.00% | -87.33% | -76.56% | -26.72% | -97.68% | -20.04% | 0.07 | — | 5.52 | 5.52 | 0.33 | -33.33% | 38.87% | -69.48% | -2.00% | -0.78 | -36.45% | 0.00% | 0.00% | 2.42% | -16.35 | -43.83 | 14.28 | 9.49 |
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($7.24 ÷ $25.87) − 1 = -72.01% (IC, example).